MAIA Biotechnology, Inc. (MAIA) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped MAIA stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: MAIA Biotechnology presents a compelling investment opportunity, driven by strong analyst consensus, recent positive clinical trial results, and strategic collaborations with major pharmaceutical firms. Despite current regulatory challenges and cash flow constraints, the potential for breakthrough in cancer treatment positions MAIA for significant growth. Analyst price targets suggest a massive upside, indicating strong belief in MAIA's innovative pipeline and partnerships. However, investors should monitor regulatory progress and financial management closely. The saved 1-year distribution is P10 $1, P50 $1.5, and P90 $125.
Last analyzed · Model: gpt-4o
MAIA Biotechnology, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $1 | Pessimistic plausible scenario |
| P50 | $1.5 | Median scenario |
| P90 | $125 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
MAIA Biotechnology has several positive indicators, including consistent analyst support, significant partnerships, and funding that position it for strong potential growth despite regulatory and cash burn concerns. The analyst consensus and targets point to substantial potential upside.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this MAIA analysis generated?
July 24, 2026.
Is this a guaranteed MAIA prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full MAIA stock analysis · MAIA sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.